TIP60-miR-22 axis as a prognostic marker of breast cancer progression

MicroRNAs (miRNAs) are 22- to 24-nucleotide, small, non-coding RNAs that bind to the 3′UTR of target genes to control gene expression. Consequently, their dysregulation contributes to many diseases, including diabetes and cancer. miR-22 is up-regulated in numerous metastatic cancers and recent studies have suggested a role for miR-22 in promoting stemness and metastasis. TIP60 is a lysine acetyl-transferase reported to be down-regulated in cancer but the molecular mechanism of this reduction is still unclear. In this study, we identify TIP60 as a target of miR-22. We show a negative correlation in the expression of TIP60 and miR-22 in breast cancer patients, and show that low levels of TIP60 and high levels of miR-22 are associated with poor overall survival. Furthermore, pathway analysis using high miR-22/low TIP60 and low miR-22/high TIP60 breast cancer patient datasets suggests association of TIP60/miR-22 with epithelial-mesenchymal transition (EMT), a key alteration in progression of cancer cells. We show that blocking endogenous miR-22 can restore TIP60 levels, which in turn decreases the migration and invasion capacity of metastatic breast cancer cell line. These results provide mechanistic insight into TIP60 regulation and evidence for the utility of the combination of TIP60 and miR-22 as prognostic indicator of breast cancer progression.

[1]  L. Banks,et al.  E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60 , 2016, Oncogene.

[2]  J. Yong,et al.  MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1. , 2015, Cancer research.

[3]  Weidong Wei,et al.  miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer. , 2015, Cancer letters.

[4]  K. Horie-Inoue,et al.  MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer , 2015, Scientific Reports.

[5]  Z. Lu,et al.  MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells , 2014, Oncogene.

[6]  T. Tan,et al.  Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.

[7]  T. Tuschl,et al.  microRNAs are biomarkers of oncogenic human papillomavirus infections , 2014, Proceedings of the National Academy of Sciences.

[8]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[9]  P. Pandolfi,et al.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. , 2013, Cell stem cell.

[10]  F. Motoi,et al.  miR‐197 induces epithelial–mesenchymal transition in pancreatic cancer cells by targeting p120 catenin , 2013, Journal of cellular physiology.

[11]  Hong Zheng,et al.  High Expression of KIF26B in Breast Cancer Associates with Poor Prognosis , 2013, PloS one.

[12]  Peng Chen,et al.  miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1 , 2013, Medical Oncology.

[13]  Anindya Dutta,et al.  Tip60 Degradation by Adenovirus Relieves Transcriptional Repression of Viral Transcriptional Activator EIA , 2012, Oncogene.

[14]  M. Martinka,et al.  Role of Tip60 in human melanoma cell migration, metastasis, and patient survival. , 2012, The Journal of investigative dermatology.

[15]  L. Wang,et al.  MicroRNA-mediated breast cancer metastasis: from primary site to distant organs , 2012, Oncogene.

[16]  H. Aburatani,et al.  Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. , 2011, Cancer research.

[17]  Takashi Takata,et al.  miR-22 represses cancer progression by inducing cellular senescence , 2011, The Journal of cell biology.

[18]  Justin M. Reitsma,et al.  Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest. , 2011, Cell host & microbe.

[19]  R. Jove,et al.  miR‐194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice , 2010, Hepatology.

[20]  C. Theillet,et al.  miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers , 2010, Oncogene.

[21]  Anindya Dutta,et al.  Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. , 2010, Molecular cell.

[22]  Chen Wu,et al.  An estrogen receptor α suppressor, microRNA‐22, is downregulated in estrogen receptor α‐positive human breast cancer cell lines and clinical samples , 2010, The FEBS journal.

[23]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[24]  H. Nemoto,et al.  Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer. , 2009, Anticancer research.

[25]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[26]  Didier Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[27]  D. Trouche,et al.  The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways , 2009, Oncogene.

[28]  John Lough,et al.  Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response , 2007, Nature.

[29]  F. Rojo,et al.  New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. , 2006, Oncology reports.

[30]  P. M. Nissom,et al.  A novel normalization method for effective removal of systematic variation in microarray data , 2006, Nucleic acids research.

[31]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[33]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[34]  C. Croce,et al.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Reuven Agami,et al.  A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.

[36]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[37]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[38]  Jun Qin,et al.  Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis , 2000, Cell.

[39]  G. Chinnadurai,et al.  Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. , 1996, Virology.

[40]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.